Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Lesaka Technologies Files Annual 10-K for Fiscal Year 2026

Lesaka Technologies, Inc. filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on September 9, 2026, covering the fiscal year ended June 30, 2026.

Vinay Lochav | 09 September 2026

Lesaka Technologies Reports Q4 and Full-Year Fiscal 2026 Results

Lesaka Technologies, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on September 9, 2026, disclosing a press release covering its financial results for the fourth quarter and fiscal year ended June 30, 2026.

Aditi Sarkar | 09 September 2026

Astrana Health CEO Surrenders Shares for Tax Withholding

Brandon Sim, CEO and President of Astrana Health, Inc. (NASDAQ:ASTH), filed a Form 4 on September 9, 2026, reporting a disposition of common stock on September 5, 2026, related to the vesting of restricted stock units.

Shwetambri Chauhan | 09 September 2026

United Therapeutics CEO Sells Shares Under 10b5-1 Plan

Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corporation, filed a Form 4 on September 9, 2026, disclosing the exercise of 9,500 stock options and the sale of 9,260 shares of common stock on September 8, 2026, pursuant to a pre-arranged Rule 10b5-1 …

Vinay Lochav | 09 September 2026

Paylocity SVP Andrew Cappotelli Sells 69 Shares

Andrew Cappotelli, Senior Vice President of Operations at Paylocity Holding Corp, filed a Form 4 on September 9, 2026, reporting a sale of common stock that occurred on September 4, 2026.

Anjali Anand | 09 September 2026

Daktronics Executive RSUs Vest Early on Retirement Date

Bradley T. Wiemann, Executive Vice President of Daktronics Inc /SD/, filed a Form 4 on September 9, 2026, disclosing the accelerated vesting of restricted stock units on September 5, 2026, his designated retirement date.

Nitish Kishor | 09 September 2026

Harmony Biosciences CMO Sells and Exercises Options in September 2026

Kumar Budur, Chief Medical Officer of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY), filed a Form 4 on September 9, 2026, disclosing a series of open-market sales and stock option exercises in common stock between September 4 and September 8, 2026.

Nitish Kishor | 09 September 2026

Artiva Biotherapeutics CEO Sells 23,429 Shares

A Form 4 filed on September 9, 2026 disclosed that Fred Aslan, Chief Executive Officer and Director of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), sold 23,429 shares of common stock on September 8, 2026 under a pre-established Rule 10b5-1 trading plan.

Aditi Sarkar | 09 September 2026

Del Monte Corp SVP Reports PSU Vesting and Share Sale

Danny Dumas, Senior Vice President of NA Sales, Marketing and Product Management at Del Monte Corp, filed a Form 4 on September 9, 2026, disclosing transactions in ordinary shares dated September 6 and September 8, 2026.

Nitish Kishor | 09 September 2026

Venture Global General Counsel Exercises and Sells 2.35M Shares

Keith D. Larson, General Counsel and Secretary of Venture Global, Inc. (NYSE:VG), filed a Form 4 on September 9, 2026, disclosing the exercise of stock options and subsequent sale of 2,350,000 shares of Class A Common Stock across two trading days.

Shwetambri Chauhan | 09 September 2026
Support

Hi! How can we help you today?

Loading…